Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Pacanowski

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|November 30, 2019
Precision Medicine 2030Michael Pacanowski, Qi Liu
Clinical Pharmacology and Therapeutics|July 19, 2021
Evidence, in Context: A Regulatory Perspective on PharmacogeneticsMichael Pacanowski, Robert N Schuck
American Family Physician|July 15, 2021
Pharmacogenetic Gene-Drug Associations: FDA Perspective on What Physicians Need to KnowWendy S Rubinstein, Michael Pacanowski
The New England Journal of Medicine|December 17, 2013
Pharmacogenetics and coumarin dosing--recalibrating expectationsIssam Zineh, Michael Pacanowski, Janet Woodcock
JAMA|May 10, 2012
New genetic discoveries and treatment for hepatitis CMichael Pacanowski, Shashi Amur, Issam Zineh
Orphanet Journal of Rare Diseases|July 26, 2024
Evaluation of the landscape of pharmacodynamic biomarkers in Niemann-Pick Disease Type C (NPC)Sydney Stern, Karryn Crisamore, Robert Schuck, et al.
Nature Reviews. Drug Discovery|December 23, 2017
Regulatory policy for the development of targeted therapies for low-frequency molecular subtypes of diseaseRobert N Schuck, Michael Pacanowski, Janet Woodcock, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 20, 2016
Clinical and regulatory considerations in pharmacogenetic testingRobert N Schuck, Elizabeth Marek, Hobart Rogers, et al.
Clinical and Translational Science|December 5, 2020
Clinical Pharmacology Studies Supporting Oligonucleotide Therapy Development: An Assessment of Therapies Approved and in Development Between 2012 and 2018Hobart Rogers, Oluseyi Adeniyi, Anuradha Ramamoorthy, et al.
Clinical and Translational Science|June 19, 2026
From Pharmacodynamic Biomarker to Evaluating Treatment Response: Biomarkers in Primary Mitochondrial DiseasesSydney Stern, Karryn Crisamore, John Patton, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|November 30, 2019
Precision Medicine 2030Michael Pacanowski, Qi Liu
Clinical Pharmacology and Therapeutics|July 19, 2021
Evidence, in Context: A Regulatory Perspective on PharmacogeneticsMichael Pacanowski, Robert N Schuck
American Family Physician|July 15, 2021
Pharmacogenetic Gene-Drug Associations: FDA Perspective on What Physicians Need to KnowWendy S Rubinstein, Michael Pacanowski
The New England Journal of Medicine|December 17, 2013
Pharmacogenetics and coumarin dosing--recalibrating expectationsIssam Zineh, Michael Pacanowski, Janet Woodcock
JAMA|May 10, 2012
New genetic discoveries and treatment for hepatitis CMichael Pacanowski, Shashi Amur, Issam Zineh
Orphanet Journal of Rare Diseases|July 26, 2024
Evaluation of the landscape of pharmacodynamic biomarkers in Niemann-Pick Disease Type C (NPC)Sydney Stern, Karryn Crisamore, Robert Schuck, et al.
Nature Reviews. Drug Discovery|December 23, 2017
Regulatory policy for the development of targeted therapies for low-frequency molecular subtypes of diseaseRobert N Schuck, Michael Pacanowski, Janet Woodcock, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 20, 2016
Clinical and regulatory considerations in pharmacogenetic testingRobert N Schuck, Elizabeth Marek, Hobart Rogers, et al.
Clinical and Translational Science|December 5, 2020
Clinical Pharmacology Studies Supporting Oligonucleotide Therapy Development: An Assessment of Therapies Approved and in Development Between 2012 and 2018Hobart Rogers, Oluseyi Adeniyi, Anuradha Ramamoorthy, et al.
Clinical and Translational Science|June 19, 2026
From Pharmacodynamic Biomarker to Evaluating Treatment Response: Biomarkers in Primary Mitochondrial DiseasesSydney Stern, Karryn Crisamore, John Patton, et al.
Pageof 5